Non-Invasive Prenatal Testing Market Share

Statistics for the 2023 & 2024 Non-Invasive Prenatal Testing market share, created by Mordor Intelligence™ Industry Reports. Non-Invasive Prenatal Testing share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Home Market Analysis Healthcare Research Medical Devices Research Diagnostic Devices Research Clinical Diagnostic Devices Research Clinical Diagnostic Laboratory Equipment Research Disease Specific Diagnostic Devices Research Genetic Testing Research Non-invasive Prenatal Testing Market Market Share

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of Non-Invasive Prenatal Testing Industry

The non-invasive prenatal testing market is very competitive, with most players competing to maximize their market shares. Strong competition, rapid technological advancements, recurrent changes in government policies, and prices are key factors that confront the market. Key market players are BGI, Eurofins Scientific, F. Hoffmann-La Roche Ltd, Invitae Corporation, Illumina Inc., Natera Inc., Qiagen, Laboratory Corp. of America Holdings, and Quest Diagnostics, among others.

Non-invasive Prenatal Testing Market Leaders

  1. BGI

  2. CENTOGENE AG

  3. Eurofins Scientific

  4. PerkinElmer Inc.

  5. F. Hoffmann-La Roche Ltd

*Disclaimer: Major Players sorted in no particular order

13.png

Non-invasive Prenatal Testing Market Report Snapshots

Non-invasive Prenatal Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)